New QC Based on Risk Management: A Collaboration between CLIA and CLSI

This webinar will provide a comprehensive overview of the Clinical and Laboratory Standards Institute (CLSI) Laboratory Quality Control Based on Risk Management; Approved Guideline, EP-23-A, produced in partnership with the Clinical Laboratory Improvement Amendment (CLIA).

Why Should You Attend:

Anyone overseeing Quality Control for a CLIA licensed laboratory should learn about the new QC option being implemented this year based on this collaboration between CLIA and CLSI. The document reviewed here provides a road map for “developing and maintaining a quality control plan (QCP)”, founded on the principles of risk management.

Areas Covered in the Seminar:

• Developing this new QC Plan based on Risk Management.
• Where to collect data and information for quality monitors?
• Definition of Risk Management Principals.
• Review of the Lab environment and the clinical application of test results.
• How to use this data to detect trends, identify corrective actions, and promote CQI?
• Pros and cons of the various tools in the Guideline.

Who Will Benefit:

• Laboratory Directors and Managers
• Clinical Lab QC Personnel
• Pathologists
• Lab Compliance Officer or Committee